Subscribe to RSS



Unexpected Volume Gainers: Signet, Multiband, Dycom, Oncolytics

Zale appointed former Signet Jewelers Ltd. (NYSE:SIG) CEO Terry Burman as its chairman, whereas the jewelry retailer as well swung to a fiscal Q3 profit in spite of a slight plunge in revenue. Analysts had currently estimates a per-share loss.

Shares of Signet Jewelers Ltd. (NYSE:SIG) opened at $72.01 with 87.18 million outstanding shares and touched its highest price of $72.52 during the day and then finished at $71.63 by scoring +0.01%. In the whole session, it traded on volume of 1.01 million shares which turned higher than its average volume.

Multiband Corp (NASDAQ:MBND) has decided to be purchased by Goodman Networks Inc. for about $71M, after a review of its options. Privately held Goodman Networks will pay $3.25 for each Multiband share, a 26 percent premium over the firm’s Tuesday closing price.

Multiband Corp (NASDAQ:MBND) stock hit highest price at $3.22, beginning with a price of $3.21 and reported a gain of +24.03% to the closed at $3.20 with a day range of $3.20-$3.22. The total market capitalization remained $69.41 million, total volume of 12.22 million shares held in the session was surprisingly higher than its average volume of 68,652 shares.
Dycom Industries, Inc. (NYSE:DY) reported that its fiscal Q3 earnings dropped 25 percent as the telecommunications contractor logged lower gains in asset sales from the year previous and as margins lessened.

Dycom Industries, Inc. (NYSE:DY) begun last trade with a price of $23.65 and throughout the trading session climbed at a high of $23.65. The day-trade ended with an advance of +8.57% to $22.16. The stock is going forward its 52 week low with 69.94% and lagging behind from its 52 week high price with -0.31%. DY last month stock price volatility remained 3.06%.

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) reported that it met its primary endpoint for the first stage of a Phase 2 clinical examination for its metastatic melanoma treatment. Shares increased 2.91% to $2.83 in afterhours trading.

Shares of Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) traded at $2.75 by increasing +1.10% with price volatility of 6.80% for a week and 4.85% for a month. Its price volatility’s Average True Range for 14 days was 0.14 and its beta stands at 1.41 times. The stock after opening at $2.97 hit high price of $3.06 and on last session stock held volume of 1.83 million shares which was unexpectedly higher than its average volume of 218,176 shares.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

Nasdaq Stocks Soared Trading Session (GWPH, REPH, XOOM, BIOF, SANM, XTLB, UNIS, RDEN, RXDX, SODA)

Nasdaq Stocks Soared Trading Session (GWPH, REPH, XOOM, BIOF, SANM, XTLB, UNIS, RDEN, RXDX, SODA)

GW Pharmaceuticals plc (Nasdaq:GWPH) soared for second day in a row, after the company was initiated on Tuesday with an Overweight rating and a price target of $103.00 per share by brokerage firm Morgan Stanley, closing at $69.32, up $8.46 (or +13.90%) GW Pharmaceuticals, focused on discovering, developing and commercializing novel therapeutics from its proprietary

Over-Surged Session Stocks: GW Pharmaceuticals PLC (Nasdaq:GWPH), IntriCon Corp (Nasdaq:IIN), Idera Pharmaceuticals Inc (Nasdaq:IDRA), Intercept Pharmaceuticals Inc (Nasdaq:ICPT), Epizyme Inc (Nasdaq:EPZM)

Over-Surged Session Stocks: GW Pharmaceuticals PLC (Nasdaq:GWPH), IntriCon Corp (Nasdaq:IIN), Idera Pharmaceuticals Inc (Nasdaq:IDRA), Intercept Pharmaceuticals Inc (Nasdaq:ICPT), Epizyme Inc (Nasdaq:EPZM)

Shares of GW Pharmaceuticals plc (Nasdaq:GWPH) are trading on different levels, after research firm Morgan Stanley initiated coverage on the company with an Overweight rating and a price target of $103.00 per share. GWPH stock is currently trading for about $63.61, up $17.57 (or +38.16%), with a volume of 4,988,786 shares traded so far. The

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

Shares of BioFuel Energy Corp. (Nasdaq:BIOF) skyrocketed on Thursday’s market activity, currently trading for about $8.20, up $2.14 (or +35.30%), and 5,845,868 of its shares exchanged hands so far BioFuel Energy recently received a preliminary non-binding proposal, which suggested the company acquire acquire all of the equity interests in real-estate developer JBGL Capital and JBGL

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Shares of Zalicus Inc. (Nasdaq:ZLCS) skyrocketed $0.32 (or +31.07%) to $1.35, following the announcement that Epirus Biopharmaceuticals, Inc., which has closed a $36 million Series B financing round, will merge with a wholly-owned subsidiary of Zalicus, to create a global biosimilar enterprise. 13,616,255 shares of Zalicus were traded on Wednesday, increased activity versus its average

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

The trading levels of SmartPros Ltd. (Nasdaq:SPRO) stock exploded on Monday’s market activity, closing at $2.99, up $0.77 (or +34.68%), and 334,315 of its shares exchanged hands during the day, a large increase on activity versus its average volume (3m) of 7,818 On intraday trading, SPRO stock reached a new 52 week high of $3.30

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2014 Crown Equity Holdings Inc. All rights reserved.